Profile data is unavailable for this security.
About the company
Jiangsu Recbio Technology Co Ltd is a China-based company mainly engaged in the research and development of vaccines. The Company has a portfolio of clinical-stage and pre-clinical stage vaccines, and its human papilloma virus (HPV) vaccine pipelines comprise of recombinant HPV 9-valent vaccine REC603, recombinant HPV 9-valent vaccines REC601 and REC602, recombinant HPV quadrivalent vaccine REC604a, and recombinant HPV 9-valent vaccine REC604b. The Company also involves in the development of Covid-19 vaccines. The Company mainly distributes products within domestic market.
- Revenue in HKD (TTM)0.00
- Net income in HKD-599.19m
- Incorporated2012
- Employees507.00
- LocationJiangsu Recbio Technology Co LtdNo. 888 Yaocheng AvenueChina Medical CityTAIZHOU ChinaCHN
- Phone+86 52 386818860
- Websitehttps://www.recbio.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIVA Biotech Holdings | 2.18bn | -347.36k | 2.08bn | 2.04k | -- | 0.5020 | 8.19 | 0.9559 | -0.0055 | -0.0055 | 1.06 | 1.93 | 0.2603 | 5.26 | 5.18 | 1,049,316.00 | 0.4017 | -1.39 | 0.5601 | -1.68 | 33.66 | 34.81 | 1.54 | -5.44 | 1.46 | 3.19 | 0.2884 | -- | -9.42 | 59.31 | 78.03 | -- | 31.98 | -- |
| Golden Throat Holdings Group Co Ltd | 1.10bn | 286.42m | 2.37bn | 860.00 | 8.26 | 1.69 | 7.19 | 2.15 | 0.3874 | 0.3874 | 1.49 | 1.90 | 0.4994 | 3.23 | 4.07 | 1,264,845.00 | 13.01 | 11.00 | 19.26 | 15.63 | 72.29 | 72.79 | 26.06 | 24.67 | 1.93 | 37.74 | 0.2814 | 83.15 | -3.09 | 6.73 | -11.04 | 19.61 | -32.13 | 38.94 |
| Cutia Therapeutics | 217.21m | -572.76m | 3.96bn | 360.00 | -- | 3.04 | -- | 18.23 | -1.88 | -1.88 | 0.7136 | 4.26 | 0.1206 | 2.31 | 6.93 | 728,907.80 | -31.81 | -- | -35.82 | -- | 50.33 | -- | -263.68 | -- | 4.82 | -- | 0.1818 | -- | 1,110.83 | -- | -253.30 | -- | -- | -- |
| Jiangsu Recbio Technology Co Ltd | 0.00 | -599.19m | 4.12bn | 507.00 | -- | 4.48 | -- | -- | -1.25 | -1.25 | 0.00 | 1.91 | 0.00 | -- | -- | 0.00 | -25.33 | -- | -32.84 | -- | -- | -- | -- | -- | 0.9619 | -- | 0.4548 | -- | -- | -- | 20.86 | -- | -- | -- |
| Ocumension Therapeutics | 338.94m | -352.52m | 4.58bn | 477.00 | -- | 1.28 | -- | 13.53 | -0.5379 | -0.5379 | 0.517 | 4.36 | 0.103 | 2.40 | 2.48 | 763,383.40 | -10.71 | -38.78 | -11.55 | -41.47 | 58.29 | 62.30 | -104.01 | -975.82 | 5.00 | -- | 0.0055 | -- | 54.99 | -- | 5.68 | -- | 319.66 | -- |
| Beijing Luzhu Biotechnology Co Ltd | 0.00 | -305.78m | 4.87bn | 148.00 | -- | 4.76 | -- | -- | -1.51 | -1.51 | 0.00 | 5.09 | 0.00 | -- | -- | 0.00 | -23.80 | -- | -25.44 | -- | -- | -- | -- | -- | 5.91 | -- | 0.0296 | -- | -- | -- | 65.62 | -- | -- | -- |
| Shandong Boan Biotechnology Co Ltd | 786.30m | 67.51m | 4.88bn | 777.00 | 68.72 | 3.05 | 34.08 | 6.21 | 0.1326 | 0.1326 | 1.54 | 2.99 | 0.3069 | 1.10 | 2.60 | 967,157.30 | 2.63 | -- | 3.43 | -- | 74.10 | -- | 8.59 | -- | 1.03 | 4.01 | 0.3369 | -- | 19.80 | -- | 64.02 | -- | -- | -- |
Data as of Nov 01 2024. Currency figures normalised to Jiangsu Recbio Technology Co Ltd's reporting currency: Hong Kong Dollar HKD
3.57%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Lake Bleu Capital (Hong Kong) Ltd.as of 20 Feb 2023 | 11.30m | 3.57% |
Data from 05 Jun 2024 - 05 Jun 2024Source: FactSet Research Systems Inc.
